Mitsubishi Chemical has given Bain first refusal right to negotiate purchase of subsidiary, Nikkei says-February 2024-www.financetom.com

Mitsubishi Chemical has given Bain first refusal right to negotiate purchase of subsidiary, Nikkei says

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Mitsubishi Chemical has given Bain first refusal right to negotiate purchase of subsidiary, Nikkei says

Jan 20, 2025 2:50 AM

TOKYO, Jan 20 (Reuters) - Mitsubishi Chemical Group ( MTLHF ) has given

the U.S. investment fund Bain Capital the right of first refusal to negotiate

the purchase of its pharmaceutical subsidiary, Tanabe Mitsubishi Pharma, the

Nikkei reported on Monday.

Mitsubishi Chemical ( MTLHF ) is likely to sell Tanabe Mitsubishi Pharma to Bain

Capital for more than 500 billion yen, the report said.

Previous page： What's Going On With Onconetix Shares Friday? Next page： --Honeywell Raises Quarterly Dividend to $1.13 a Share From $1.08, Payable Dec. 6 to Holders of Record on Nov. 15

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

What's Going On With Onconetix Shares Friday?

Oct 3, 2024

Onconetix, Inc. ( ONCO ) stock is moving higher Friday. Altos Venture filed a Form 13D with the Securities and Exchange Commission on Thursday, reporting a 32.5% stake in the company as of September 24. What To Know: The 32.5% stake in Onconetix ( ONCO ) equates to 2,695,931 shares, which Altos acquired through multiple transactions. The position includes shares...

--Honeywell Raises Quarterly Dividend to $1.13 a Share From $1.08, Payable Dec. 6 to Holders of Record on Nov. 15

Oct 3, 2024

10:56 AM EDT, 09/27/2024 (MT Newswires) -- Price: 209.77, Change: +2.74, Percent Change: +1.32 ...

Learning Technologies likely to recommend General Atlantic's proposed takeover offer

Oct 3, 2024

Sept 27 (Reuters) - Learning Technologies Group on Friday confirmed that the U.S. private equity investor General Atlantic has approached it with a possible cash offer to acquire the corporate education group. Learning Technologies said it was minded to recommend the proposed offer of 100 pence per LTG share and has provided access to confirmatory due diligence to General Atlantic....

Lexaria Bioscience Receives Approval From Independent Review Board for Pilot Study of Tirzepatide

Oct 3, 2024

10:54 AM EDT, 09/27/2024 (MT Newswires) -- Lexaria Bioscience ( LEXX ) said Friday that an unnamed independent review board has approved the firm's human pilot study 3 to evaluate a DehydraTECH-processed version of glucagon-like peptide, or GLP-1, plus glucose-dependent insulinotropic peptide, or GIP, tirzepatide in an oral dose format. The subject recruitment will start shortly and the first dosing...